We observed the gene signature (CXCL9 + CXCL10 + IDO1 + IFNG + HLADRA + STAT1 + FOXP3 + CD4 + CD8) predicted prolonged survival of patients in larger GC cohorts (Figure 6d). The gene discussed is HLA-DRA; the disease is gastric cancer.